The Challenge

Reviewers and auditors cannot see where a CSR statement came from or how AI was used. Protocol amendments, SAP updates and TLF reruns arrive without a record of which CSR text depends on them, so amendment references risk going stale. Review runs sequentially, writer → biostatistics → clinical review, and consistency is checked by reading.

Key Challenges

  • AI use isn’t on the record: Nothing shows which statements AI produced, what they rest on, or how reliable they are.
  • Oversight spread across handoffs: Writer → biostatistics → clinical review leaves approval split across people and versions.
  • Checks leave no trace: Cross-document consistency is verified by reading, with no record of what was checked.
  • Numbers lack a verification record: About 150 TLFs are retyped into Sections 10–12 and hand-checked, with no proof of verification.

Our Solution

CSR Studio lets Regulatory Operations and QA adopt AI in CSR authoring without giving up control. Writers keep authorship, and a human approves every section before it moves on.

1
Democratized Data Access
Developed a non-SQL method for querying data within the EDF, eliminating the need for SQL knowledge.

Every claim answerable:
Each statement and number is cited to study data, so a regulatory question (FDA, EMA, PMDA) points straight to its source.

2

Amendments stay current:
Stale protocol and amendment references are flagged before the CSR goes forward.

3

Independent verification:
A separate cross-check confirms every citation against the source value.

4

Automated QC before review:
Deterministic checks catch numeric mismatches and inconsistencies, so reviewers see a cleaner draft.

5

Risk-based review:
High / Medium / Low confidence ratings and SME routing direct effort to flagged items.

Key Impact
100%
Numeric statements designed to be traceable to their sources
3 confidence tiers
High / Medium / Low on every claim
The Customer
Regulatory Operations and Quality Assurance teams responsible for the CSR submitted to regulators (FDA, EMA, PMDA), working with medical writing and clinical review.

The Outcomes

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Defensible Submissions:
100% of numeric statements are designed to be traceable to source, so Regulatory Operations can answer regulator questions with evidence.

Controls QA Can Rely On:
An independent cross-check and deterministic QC verify claims before they reach a reviewer.

Human Accountability at Every Gate:
5 checkpoints mean no section finalizes without sign-off, and 6 AI agents stay inside that workflow.

Review Where It Matters:
Confidence ratings and SME routing focus reviewer attention on flagged items.

Recent Case Studies

Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more